Healthcare provider profile · identity verified

Thomas Jeffery, APRN

Nurse Practitioner · TAMPA, FL · NPI 1821476094

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Divalproex Sodium	Divalproex Sodium	613	76
Gabapentin	Gabapentin	452	62
Trazodone Hcl	Trazodone Hcl	437	65
Clonazepam	Clonazepam	342	47
Quetiapine Fumarate	Quetiapine Fumarate	316	36
Lorazepam	Lorazepam	314	58
Olanzapine	Olanzapine	294	38
Alprazolam	Alprazolam	279	42
Risperidone	Risperidone	274	38
Mirtazapine	Mirtazapine	209	27
Escitalopram Oxalate	Escitalopram Oxalate	141	16
Buspirone Hcl	Buspirone Hcl	134	17
Memantine Hcl	Memantine Hcl	133	17
Donepezil Hcl	Donepezil Hcl	125	19
Lamotrigine	Lamotrigine	118	17
Duloxetine Hcl	Duloxetine Hcl	113	17
Benztropine Mesylate	Benztropine Mesylate	97	suppressed
Paroxetine Hcl	Paroxetine Hcl	96	suppressed
Sertraline Hcl	Sertraline Hcl	87	17
Ziprasidone Hcl	Ziprasidone Hcl	81	suppressed
Temazepam	Temazepam	75	11
Aripiprazole	Aripiprazole	70	11
Topiramate	Topiramate	66	suppressed
Oxcarbazepine	Oxcarbazepine	65	suppressed
Carbamazepine	Carbamazepine	64	suppressed
Levetiracetam	Levetiracetam	64	suppressed
Citalopram Hbr	Citalopram Hydrobromide	63	11
Clonidine Hcl	Clonidine Hcl	59	suppressed
Lithium Carbonate	Lithium Carbonate	59	suppressed
Olanzapine Odt	Olanzapine	59	suppressed
Bupropion Xl	Bupropion Hcl	52	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	52	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	52	suppressed
Divalproex Sodium Er	Divalproex Sodium	48	suppressed
Haloperidol	Haloperidol	48	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	44	suppressed
Guanfacine Hcl Er	Guanfacine Hcl	41	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	37	suppressed
Risperidone Odt	Risperidone	37	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Naltrexone Hcl	Naltrexone Hcl	35	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	34	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	33	suppressed
Amlodipine Besylate	Amlodipine Besylate	32	suppressed
Eliquis	Apixaban	31	suppressed
Pregabalin	Pregabalin	29	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	28	suppressed
Clozapine	Clozapine	27	suppressed
Famotidine	Famotidine	27	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	11
Levothyroxine Sodium	Levothyroxine Sodium	26	suppressed
Estradiol	Estradiol	25	suppressed
Bupropion Hcl	Bupropion Hcl	24	suppressed
Atorvastatin Calcium	Atorvastatin Calcium	22	suppressed
Lisinopril	Lisinopril	22	suppressed
Perphenazine	Perphenazine	22	suppressed
Risperdal Consta	Risperidone Microspheres	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Prazosin Hcl	Prazosin Hcl	19	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	18	suppressed
Caplyta	Lumateperone Tosylate	17	suppressed
Celecoxib	Celecoxib	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Desmopressin Acetate	Desmopressin Acetate	17	suppressed
Paliperidone Er	Paliperidone	17	suppressed
Belsomra	Suvorexant	16	suppressed
Ingrezza	Valbenazine Tosylate	16	suppressed
Invega Sustenna	Paliperidone Palmitate	15	suppressed
Metformin Hcl	Metformin Hcl	15	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	15	suppressed
Glimepiride	Glimepiride	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Naproxen	Naproxen	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Furosemide	Furosemide	12	suppressed
Galantamine Hbr	Galantamine Hbr	12	suppressed
Montelukast Sodium	Montelukast Sodium	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Rexulti	Brexpiprazole	12	suppressed
Fanapt	Iloperidone	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Tiagabine Hcl	Tiagabine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error